N6-Isotope-Labeled Ergot Alkaloid Synthesis for HPLC-MS/MS Accuracy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The lack of commercially available isotopically labeled ergot alkaloids limits the accurate quantification of ergot alkaloids and their epimers in cereals and cereal-based products, leading to reduced accuracy and precision in HPLC-MS/MS analysis due to matrix effects, which is exacerbated by the introduction of stricter regulatory limits on ergot alkaloid levels.

Innovation Solution

A two-step synthesis method involving demethylation and remethylation of unlabeled ergot alkaloids using stable isotopes to create N 6< -isotope-labeled ergot alkaloids, which can be used as internal standards in HPLC-MS analysis, ensuring higher yields and lower production costs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If isotopically labeled ergot alkaloids are used as internal standards in HPLC-MS/MS analysis, then measurement precision and accuracy are improved, but the lack of commercially available labeled compounds prevents their use

Engineering Contradiction:
Improvequantification accuracyVSAvoidavailability of labeled standards
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent applies preliminary action by performing demethylation of the ergot alkaloid structure before remethylation with the isotopically labeled methyl group. This preparatory step creates the necessary reactive intermediate (norergot alkaloid) that enables subsequent introduction of the labeled methyl group at the N6 position, thereby producing the desired isotopically labeled internal standard

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses the norergot alkaloid as an intermediary compound in the synthesis pathway. The demethylated norergot alkaloid serves as a mediator that facilitates the introduction of the isotopically labeled methyl group, enabling the transformation from unlabeled ergot alkaloid to isotopically labeled ergot alkaloid through this intermediate structure

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If complex multi-step synthesis methods are used to produce isotopically labeled ergot alkaloids, then labeled standards can be obtained, but the synthesis becomes more expensive and less efficient

Engineering Contradiction:
Improveyield of labeled standardsVSAvoidnumber of synthesis steps
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent segments the synthesis into two distinct sequential steps: first demethylation to form the norergot alkaloid intermediate, then remethylation with the isotopically labeled methyl group. This segmentation allows each step to be optimized independently and simplifies the overall synthesis pathway compared to attempting direct labeling

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs parameter changes by modifying the methyl group at the N6 position from an unlabeled methyl group in the original ergot alkaloid to an isotopically labeled methyl group (13C, 15N, or 2H) in the final product. This parameter change at a specific molecular position enables the creation of the isotopically labeled internal standard through controlled chemical transformation

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method allows for reliable and cost-effective production of isotopically labeled ergot alkaloids, enhancing the accuracy and precision of ergot alkaloid quantification in compliance with regulatory standards, thereby ensuring safe food production.

Implementation Method 1

The synthesis comprises firstly demethylating the ergot alkaloid... The demethylating is carried out in the presence of an iron-containing catalyst

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

demethylating the ergot alkaloid and secondly remethylating the ergot alkaloid with an isotopically labeled methyl group

Methodology Applied
Scientific EffectRedox Reactions: Redox Reactions

Implementation Method 3

remethylating the ergot alkaloid with an isotopically labeled methyl group... The isotopically labeled methyl group can include any of 13C, 15N, and 2H

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Data Source

PatentEP4620936A1Process for the preparation of n6-isotope-labeled ergot alkaloids, in particular lysergic acid amides and ergopeptines
Publication Date: 2025.09.24 BUNDESREPUBLIK DEUTSCHLAND VERTRETEN DURCH DEN BUNDESMINISTER FÜR WIRTSCHAFT & KLIMASCHUTZ DIESER VERTRETEN DURCH DEN PRÄSIDENTEN DER
  • EP4620936A1 patent drawingFigure 1
  • EP4620936A1 patent drawingFigure 2
  • EP4620936A1 patent drawingFigure 3

AI summary

A process of synthesizing an N6-isotope-labeled ergot alkaloid is suggested, comprising: demethylating the ergot alkaloid to obtain a corresponding N6-demethylated norergot alkaloid; remethylating the corresponding N6-demethylated norergot alkaloid to obtain the N6-isotopically labeled ergot alkaloid; wherein remethylating is carried out with an isotopically labeled methylation reagent.